Advisory Committee on Immunization Practices (ACIP)
The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.
Select all docs (Max 200)
Narrow Results:
More
More
More
More
More
More
Publish Year
- 2023 1
- 2022 188
- 2021 240
- 2020 129
- 2019 104
- 2018 133
- 2017 116
- 2016 98
- 2015 77
- 2014 117
- 2013 102
- 2012 110
- 2011 14
- 2010 20
- 2009 14
- 2008 14
- 2007 10
- 2006 13
- 2005 9
- 2004 8
- 2003 16
- 2002 12
- 2001 6
- 2000 13
- 1999 10
- 1998 5
- 1997 10
- 1996 11
- 1995 4
- 1994 7
- 1993 5
- 1992 5
- 1991 9
- 1990 6
- 1989 5
- 1988 4
- 1987 4
- 1986 4
- 1985 3
- 1984 4
- 1983 3
- 1982 3
- 1981 3
- 1980 2
- 1979 3
- 1978 3
- 1977 3
- 1976 7
- 1975 3
- 1974 3
- 1973 2
- 1972 3
- 1971 3
- 1970 2
- 1969 4
- 1968 3
- 1967 3
- 1966 2
- 1965 2
- 1954 1
Genre
- Abbreviations 1
- Bibliography 1
- Blogs 1
- Chronology 1
- Conference Publications 1382
- Fact Sheet 2
- Guidance 12
- Guideline 8
- Guidelines 1
- Historical Article 1
- Map 1
- Practice Guideline 76
- Review 1
- Standards 2
Document Type
- Agenda 70
- Guideline 1
- HAN Health Update 1
- Journal Article 128
- Journal Issue 100
- Minutes 201
- Newsletter 2
- Pamphlet (or booklet) 34
- Presentation 1118
- Published Erratum 1
- Report 5
- Table 1
- Webpage 4
Subject
- administration & dosage 32
- Adolescent 107
- Adult 110
- Adverse Drug Reaction Reporting Systems 29
- adverse effects 20
- Advisory Committees 64
- Aged 49
- Aged, 80 and over 12
- Age Factors 17
- Anthrax Vaccines 17
- Antiviral Agents 20
- Articles 17
- Chickenpox Vaccine 12
- Child 131
- Child, Preschool 99
- Cholera Vaccines 12
- Communicable Disease Control/standards 13
- contraindications 13
- Coronavirus Infections 17
- Coronavirus Infections/prevention &control 46
- Coronavirus Infections/prevention & control 197
- COVID-19 64
- COVID-19 Vaccines 221
- COVID-19 Vaccines/adverse effects 22
- COVID-19/prevention & control 96
- Decision Making 19
- Dengue 13
- Dengue Vaccines 22
- Diphtheria-Tetanus-acellular Pertussis Vaccines 22
- Disease Outbreaks 30
- Drug-Related Side Effects and Adverse Reactions 13
- Ebola Vaccines 17
- Female 35
- Full Report 21
- GRADE Approach 37
- Haemophilus Vaccines 12
- Health Personnel 21
- Hepatitis A Vaccines 29
- Hepatitis B 12
- Hepatitis B Vaccines 43
- Herpes Zoster Vaccine 37
- Humans 150
- Immunization 340
- Immunization, Secondary 72
- Immunization/standards 49
- Immunization Programs 312
- Immunization Schedule 181
- Immunocompromised Host 16
- Infant 94
- Infant, Newborn 32
- Influenza, Human 48
- Influenza, Human/prevention & control 16
- Influenza A virus 13
- Influenza A Virus, H1N1 Subtype 13
- Influenza B virus 19
- Influenza Vaccines 162
- Influenza Vaccines/adverse effects 12
- Influenza Vaccines 12
- Japanese Encephalitis Vaccines 32
- Licensure 12
- Male 27
- Mass Vaccination 12
- Measles-Mumps-Rubella Vaccine 29
- Meningococcal Infections 17
- Meningococcal Vaccines 89
- Middle Aged 50
- Myocarditis 13
- Pandemics 150
- Papillomavirus Vaccines 53
- Papillomavirus Vaccines 34
- Patient Safety 44
- Pertussis Vaccine 34
- Pneumococcal Infections 14
- Pneumococcal Vaccines 77
- Practice Guidelines as Topic 34
- Pregnancy 35
- prevention & control 34
- Program Evaluation 15
- Public Health Surveillance 13
- Rabies Vaccines 12
- Respiratory Syncytial Virus Infections/prevention & control 13
- Respiratory Syncytial Virus Vaccines 16
- Risk Factors 16
- Safety 27
- Seasons 14
- Smallpox Vaccine 16
- standards 43
- Travel 19
- Vaccination 592
- Vaccination/adverse effects 14
- Vaccination/standards 22
- Vaccines 329
- Vaccines, Attenuated 22
- Vaccines, Combined 21
- Vaccines, Conjugate 20
- Vaccines, Inactivated 22
- Vaccines/administration & dosage 47
- Vaccines/supply & distribution 18
- Viral Vaccines 158
- Young Adult 29
Name as Subject
- ACIP Meeting 2021 January 27 4
- ACIP meeting: 2003 Oct 3
- ACIP meeting: 2012 Jun 5
- ACIP meeting: 2012 Oct 37
- ACIP meeting: 2013 Feb 28
- ACIP meeting: 2013 Jun 28
- ACIP meeting: 2013 Oct 33
- ACIP meeting: 2014 Aug 4
- ACIP meeting: 2014 Feb 33
- ACIP meeting: 2014 Jun 37
- ACIP meeting: 2014 Oct 29
- ACIP meeting: 2015 Feb 13
- ACIP meeting: 2015 Jun 31
- ACIP meeting: 2015 Oct 22
- ACIP meeting: 2016 Feb 22
- ACIP meeting: 2016 Jun 35
- ACIP meeting: 2016 Oct 39
- ACIP meeting: 2017 Feb 35
- ACIP meeting: 2017 Jun 29
- ACIP meeting: 2017 Oct 50
- ACIP meeting: 2018 Feb 35
- ACIP meeting: 2018 Jun 30
- ACIP meeting: 2018 Oct 36
- ACIP meeting: 2019 Feb 38
- ACIP meeting: 2019 Jun 33
- ACIP meeting: 2019 Oct 20
- ACIP meeting: 2020 Aug 8
- ACIP meeting: 2020 Dec 01 5
- ACIP meeting: 2020 Dec 11 5
- ACIP meeting: 2020 Dec 11-12 3
- ACIP meeting: 2020 Dec 19-20 10
- ACIP meeting: 2020 Feb 26
- ACIP meeting: 2020 Jul 11
- ACIP meeting: 2020 Jun 14
- ACIP meeting: 2020 Nov 9
- ACIP meeting: 2020 Oct 13
- ACIP meeting: 2020 Sep 10
- ACIP meeting: 2021 Apr. 14 5
- ACIP meeting: 2021 Apr. 23 6
- ACIP meeting: 2021 Aug 13 6
- ACIP meeting: 2021 Aug 30 9
- ACIP meeting: 2021 Feb-Mar 11
- ACIP meeting: 2021 Feb 24-25 20
- ACIP meeting: 2021 Jan 10
- ACIP meeting: 2021 Jun 23 10
- ACIP meeting: 2021 Jun 24 12
- ACIP meeting: 2021 Jun 25 8
- ACIP meeting: 2021 May 5 6
- ACIP meeting: 2021 May 12 9
- ACIP meeting: 2021 Nov 2 8
- ACIP meeting: 2021 Nov 3 10
- ACIP meeting: 2021 Nov 19 8
- ACIP meeting: 2021 Oct 20 7
- ACIP meeting: 2021 Oct 21 12
- ACIP meeting: 2021 Sep 22-23 15
- ACIP meeting: 2021 Sep 29 14
- ACIP meeting: 2022 Feb 4 12
- ACIP meeting: 2022 Feb 23-24 17
- ACIP meeting: 2022 Jan 5 4
- ACIP meeting: 2022 Jan 12 14
- ACIP meeting: 2022 Jul 19 6
- ACIP meeting: 2022 Jun 17 5
- ACIP meeting: 2022 Jun 18 5
- ACIP meeting: 2022 Jun 22-23 55
- ACIP meeting: 2022 May 19 6
- ACIP meeting: 2022 October 19-20 12
- ACIP meeting: 2022 Sep 1-2 8
- Adolescent 3
- Centers for Disease Control and Prevention (U.S.) 10
- Child 7
- Coronavirus Infections/prevention & control 16
- Coronavirus Infections/prevention &control 4
- COVID-19 Vaccines 15
- COVID-19 Vaccines/adverse effects 5
- GRADE Approach 6
- Immunization, Secondary 4
- Influenza, Human 3
- Influenza Vaccines 4
- Janssen COVID-19 vaccine 8
- Janssen COVID-19 Vaccine 9
- Johnson & Johnson’s Janssen COVID-19 vaccine 5
- Moderna COVID-19 Vaccine 8
- Moderna COVID-19 vaccine 18
- Novavax vaccine 3
- Pandemics 11
- Patient Safety 5
- Pfizer-BioNTech COVID-19 vaccine 24
- Pfizer-BioNTech COVID-19 Vaccine 14
- Pneumococcal Infections 4
- Pneumococcal Vaccines 5
- Safety-Based Drug Withdrawals 3
- Thrombocytopenia 4
- Thrombosis 4
- United States. Advisory Committee on Immunization Practices. 7
- United States. Food and Drug Administration. 6
- Vaccination 17
- Vaccine Adverse Event Reporting System 4
- Vaccines 3
- Vaccine Safety Datalink 6
- Viral Vaccines 12
Place as Subject
- Africa 1
- Alabama 1
- Americas 1
- Arizona 1
- Asia 5
- Australia 2
- Colorado 1
- District of Columbia 1
- Indiana 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 1
- Minnesota 1
- New Jersey 1
- New Mexico 1
- New York City, NY 1
- New Zealand 1
- North Carolina 1
- Puerto Rico 3
- Rhode Island 1
- Seattle, WA 1
- Sierra Leone 1
- South America 1
- United States 250
- Utah 1
- Washington 1
Select all docs (Max 200)
1701 -
1718 of 1718 Results
Refine Results
Refine Results:
- 2023 (1)
- 2022 (188)
- 2021 (240)
- 2020 (129)
- 2019 (104)
- 2018 (133)
- 2017 (116)
- 2016 (98)
- 2015 (77)
- 2014 (117)
- 2013 (102)
- 2012 (110)
- 2011 (14)
- 2010 (20)
- 2009 (14)
- 2008 (14)
- 2007 (10)
- 2006 (13)
- 2005 (9)
- 2004 (8)
- 2003 (16)
- 2002 (12)
- 2001 (6)
- 2000 (13)
- 1999 (10)
- 1998 (5)
- 1997 (10)
- 1996 (11)
- 1995 (4)
- 1994 (7)
- 1993 (5)
- 1992 (5)
- 1991 (9)
- 1990 (6)
- 1989 (5)
- 1988 (4)
- 1987 (4)
- 1986 (4)
- 1985 (3)
- 1984 (4)
- 1983 (3)
- 1982 (3)
- 1981 (3)
- 1980 (2)
- 1979 (3)
- 1978 (3)
- 1977 (3)
- 1976 (7)
- 1975 (3)
- 1974 (3)
- 1973 (2)
- 1972 (3)
- 1971 (3)
- 1970 (2)
- 1969 (4)
- 1968 (3)
- 1967 (3)
- 1966 (2)
- 1965 (2)
- 1954 (1)
- administration & dosage (32)
- Adolescent (107)
- Adult (110)
- Adverse Drug Reaction Reporting Systems (29)
- adverse effects (20)
- Advisory Committees (64)
- Aged (49)
- Aged, 80 and over (12)
- Age Factors (17)
- Anthrax Vaccines (17)
- Antiviral Agents (20)
- Articles (17)
- Chickenpox Vaccine (12)
- Child (131)
- Child, Preschool (99)
- Cholera Vaccines (12)
- Communicable Disease Control/standards (13)
- contraindications (13)
- Coronavirus Infections (17)
- Coronavirus Infections/prevention &control (46)
- Coronavirus Infections/prevention & control (197)
- COVID-19 (64)
- COVID-19 Vaccines (221)
- COVID-19 Vaccines/adverse effects (22)
- COVID-19/prevention & control (96)
- Decision Making (19)
- Dengue (13)
- Dengue Vaccines (22)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (22)
- Disease Outbreaks (30)
- Drug-Related Side Effects and Adverse Reactions (13)
- Ebola Vaccines (17)
- Female (35)
- Full Report (21)
- GRADE Approach (37)
- Haemophilus Vaccines (12)
- Health Personnel (21)
- Hepatitis A Vaccines (29)
- Hepatitis B (12)
- Hepatitis B Vaccines (43)
- Herpes Zoster Vaccine (37)
- Humans (150)
- Immunization (340)
- Immunization, Secondary (72)
- Immunization/standards (49)
- Immunization Programs (312)
- Immunization Schedule (181)
- Immunocompromised Host (16)
- Infant (94)
- Infant, Newborn (32)
- Influenza, Human (48)
- Influenza, Human/prevention & control (16)
- Influenza A virus (13)
- Influenza A Virus, H1N1 Subtype (13)
- Influenza B virus (19)
- Influenza Vaccines (162)
- Influenza Vaccines/adverse effects (12)
- Influenza Vaccines (12)
- Japanese Encephalitis Vaccines (32)
- Licensure (12)
- Male (27)
- Mass Vaccination (12)
- Measles-Mumps-Rubella Vaccine (29)
- Meningococcal Infections (17)
- Meningococcal Vaccines (89)
- Middle Aged (50)
- Myocarditis (13)
- Pandemics (150)
- Papillomavirus Vaccines (53)
- Papillomavirus Vaccines (34)
- Patient Safety (44)
- Pertussis Vaccine (34)
- Pneumococcal Infections (14)
- Pneumococcal Vaccines (77)
- Practice Guidelines as Topic (34)
- Pregnancy (35)
- prevention & control (34)
- Program Evaluation (15)
- Public Health Surveillance (13)
- Rabies Vaccines (12)
- Respiratory Syncytial Virus Infections/prevention & control (13)
- Respiratory Syncytial Virus Vaccines (16)
- Risk Factors (16)
- Safety (27)
- Seasons (14)
- Smallpox Vaccine (16)
- standards (43)
- Travel (19)
- Vaccination (592)
- Vaccination/adverse effects (14)
- Vaccination/standards (22)
- Vaccines (329)
- Vaccines, Attenuated (22)
- Vaccines, Combined (21)
- Vaccines, Conjugate (20)
- Vaccines, Inactivated (22)
- Vaccines/administration & dosage (47)
- Vaccines/supply & distribution (18)
- Viral Vaccines (158)
- Young Adult (29)
- ACIP Meeting 2021 January 27 (4)
- ACIP meeting: 2003 Oct (3)
- ACIP meeting: 2012 Jun (5)
- ACIP meeting: 2012 Oct (37)
- ACIP meeting: 2013 Feb (28)
- ACIP meeting: 2013 Jun (28)
- ACIP meeting: 2013 Oct (33)
- ACIP meeting: 2014 Aug (4)
- ACIP meeting: 2014 Feb (33)
- ACIP meeting: 2014 Jun (37)
- ACIP meeting: 2014 Oct (29)
- ACIP meeting: 2015 Feb (13)
- ACIP meeting: 2015 Jun (31)
- ACIP meeting: 2015 Oct (22)
- ACIP meeting: 2016 Feb (22)
- ACIP meeting: 2016 Jun (35)
- ACIP meeting: 2016 Oct (39)
- ACIP meeting: 2017 Feb (35)
- ACIP meeting: 2017 Jun (29)
- ACIP meeting: 2017 Oct (50)
- ACIP meeting: 2018 Feb (35)
- ACIP meeting: 2018 Jun (30)
- ACIP meeting: 2018 Oct (36)
- ACIP meeting: 2019 Feb (38)
- ACIP meeting: 2019 Jun (33)
- ACIP meeting: 2019 Oct (20)
- ACIP meeting: 2020 Aug (8)
- ACIP meeting: 2020 Dec 01 (5)
- ACIP meeting: 2020 Dec 11 (5)
- ACIP meeting: 2020 Dec 11-12 (3)
- ACIP meeting: 2020 Dec 19-20 (10)
- ACIP meeting: 2020 Feb (26)
- ACIP meeting: 2020 Jul (11)
- ACIP meeting: 2020 Jun (14)
- ACIP meeting: 2020 Nov (9)
- ACIP meeting: 2020 Oct (13)
- ACIP meeting: 2020 Sep (10)
- ACIP meeting: 2021 Apr. 14 (5)
- ACIP meeting: 2021 Apr. 23 (6)
- ACIP meeting: 2021 Aug 13 (6)
- ACIP meeting: 2021 Aug 30 (9)
- ACIP meeting: 2021 Feb-Mar (11)
- ACIP meeting: 2021 Feb 24-25 (20)
- ACIP meeting: 2021 Jan (10)
- ACIP meeting: 2021 Jun 23 (10)
- ACIP meeting: 2021 Jun 24 (12)
- ACIP meeting: 2021 Jun 25 (8)
- ACIP meeting: 2021 May 5 (6)
- ACIP meeting: 2021 May 12 (9)
- ACIP meeting: 2021 Nov 2 (8)
- ACIP meeting: 2021 Nov 3 (10)
- ACIP meeting: 2021 Nov 19 (8)
- ACIP meeting: 2021 Oct 20 (7)
- ACIP meeting: 2021 Oct 21 (12)
- ACIP meeting: 2021 Sep 22-23 (15)
- ACIP meeting: 2021 Sep 29 (14)
- ACIP meeting: 2022 Feb 4 (12)
- ACIP meeting: 2022 Feb 23-24 (17)
- ACIP meeting: 2022 Jan 5 (4)
- ACIP meeting: 2022 Jan 12 (14)
- ACIP meeting: 2022 Jul 19 (6)
- ACIP meeting: 2022 Jun 17 (5)
- ACIP meeting: 2022 Jun 18 (5)
- ACIP meeting: 2022 Jun 22-23 (55)
- ACIP meeting: 2022 May 19 (6)
- ACIP meeting: 2022 October 19-20 (12)
- ACIP meeting: 2022 Sep 1-2 (8)
- Adolescent (3)
- Centers for Disease Control and Prevention (U.S.) (10)
- Child (7)
- Coronavirus Infections/prevention & control (16)
- Coronavirus Infections/prevention &control (4)
- COVID-19 Vaccines (15)
- COVID-19 Vaccines/adverse effects (5)
- GRADE Approach (6)
- Immunization, Secondary (4)
- Influenza, Human (3)
- Influenza Vaccines (4)
- Janssen COVID-19 vaccine (8)
- Janssen COVID-19 Vaccine (9)
- Johnson & Johnson’s Janssen COVID-19 vaccine (5)
- Moderna COVID-19 Vaccine (8)
- Moderna COVID-19 vaccine (18)
- Novavax vaccine (3)
- Pandemics (11)
- Patient Safety (5)
- Pfizer-BioNTech COVID-19 vaccine (24)
- Pfizer-BioNTech COVID-19 Vaccine (14)
- Pneumococcal Infections (4)
- Pneumococcal Vaccines (5)
- Safety-Based Drug Withdrawals (3)
- Thrombocytopenia (4)
- Thrombosis (4)
- United States. Advisory Committee on Immunization Practices. (7)
- United States. Food and Drug Administration. (6)
- Vaccination (17)
- Vaccine Adverse Event Reporting System (4)
- Vaccines (3)
- Vaccine Safety Datalink (6)
- Viral Vaccines (12)
- Africa (1)
- Alabama (1)
- Americas (1)
- Arizona (1)
- Asia (5)
- Australia (2)
- Colorado (1)
- District of Columbia (1)
- Indiana (1)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (1)
- Minnesota (1)
- New Jersey (1)
- New Mexico (1)
- New York City, NY (1)
- New Zealand (1)
- North Carolina (1)
- Puerto Rico (3)
- Rhode Island (1)
- Seattle, WA (1)
- Sierra Leone (1)
- South America (1)
- United States (250)
- Utah (1)
- Washington (1)
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
[PDF - 200.12 KB]
Corporate Authors:
National Center for Immunization and Respiratory Diseases (U.S.) ...
September 18, 2014
Description:
This easy-to-read schedule was updated September 18, 2014 to reflect the latest pneumococcal vaccination recommendations from the Advisory Committee o...
Status:
current
File Type:
[PDF - 200.12 KB]
File Type:
[PDF - 200.12 KB]
Advisory Committee on Immunization Practices (ACIP) and the childhood immunization schedule
Cite
[PDF - 252.57 KB]
Corporate Authors:
United States. Advisory Committee on Immunization Practices. ...
January 2018
Description:
• The Centers for Disease Control and Prevention (CDC) sets the U.S. childhood immunization schedule based on recommendations from the Advisory Comm...
File Type:
[PDF - 252.57 KB]
File Type:
[PDF - 252.57 KB]
Guidelines for vaccinating dialysis patients and patients with chronic kidney disease; summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP)
Cite
[PDF - 833.32 KB]
Personal Author:
Chi, Carolyn ;
Moore, Matt
...
December 2012
Description:
This summary is not meant to apply to chronic kidney disease patients who are recently post-transplant. These patients are considered more significant...
Status:
current
File Type:
[PDF - 833.32 KB]
File Type:
[PDF - 833.32 KB]
Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2017-18
Cite
[PDF - 1.34 MB]
Corporate Authors:
United States. Advisory Committee on Immunization Practices.
January 26, 2018
Description:
updated January 26, 2018For additional information: MMWR Recomm Rep 2017;66(RR-2):1-20 (https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.h...
File Type:
[PDF - 1.34 MB]
File Type:
[PDF - 1.34 MB]
Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Cite
[PDF - 317.21 KB]
Personal Author:
Levine, Orin S. ;
Schwartz, Benjamin
...
October 6, 2000 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-9 PMID:11055835:MODS 11055835
Description:
In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use ...
File Type:
[PDF - 317.21 KB]
File Type:
[PDF - 317.21 KB]
[PDF - 717.96 KB]
Personal Author:
Ahmed, Faruque.
November 1, 2013
Description:
The U.S. Advisory Committee on Immunization Practices (ACIP) provides expert external advice and guidance to the Director of the Centers for Disease C...
File Type:
[PDF - 717.96 KB]
File Type:
[PDF - 717.96 KB]
Prevention of hepatitis A through active or passive immunization : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Cite
[PDF - 394.11 KB]
Personal Author:
Bell, Beth P. ;
Margolis, Harold S.
...
December 27, 1996 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 45, no. RR-15
Description:
This report provides recommendations for use of the newly licensed hepatitis A vaccines (HAVRIX, manufactured by SmithKline Beecham Biologicals, and V...
Status:
superseded
File Type:
[PDF - 394.11 KB]
File Type:
[PDF - 394.11 KB]
[PDF - 189.91 KB]
Corporate Authors:
United States, Advisory Committee on Immunization Practices. ...
2012
File Type:
[PDF - 189.91 KB]
File Type:
[PDF - 189.91 KB]
[PDF - 236.60 KB]
Personal Author:
Wharton, Melinda ;
Anderson, Larry J.
...
April 4, 2003 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-7
Description:
This report supplements the 2001 statement by the Advisory Committee on Immunization Practices (ACIP) (CDC. Vaccinia [smallpox] vaccine: recommendatio...
File Type:
[PDF - 236.60 KB]
File Type:
[PDF - 236.60 KB]
[PDF - 231.99 KB]
Personal Author:
Averhoff, Francisco ;
Hadler, Stephen C.
...
November 22, 1996 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 45, no. RR-13
Description:
This report concerning the immunization of adolescents (i.e., persons 11-21 years of age, as defined by the American Medical Association {AMA} and the...
File Type:
[PDF - 231.99 KB]
File Type:
[PDF - 231.99 KB]